輸入代號或公司名稱後按 Enter
4160

訊聯基因

-0.65 (-1.64%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
38.908成交張數59.03本益比2.14股價淨值比1.25%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025603年增 -8.9%
毛利率202541.5%最新一期
營業利益率20252.0%最新一期
每股盈餘20250.80年增 -61.0%
會計項目走勢2016201720182019202020212022202320242025
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
營業成本合計73.4%66.2%61.1%61.0%68.1%62.4%58.7%60.0%57.7%58.5%
營業毛利(毛損)26.6%33.8%38.9%39.0%31.9%37.6%41.3%40.0%42.3%41.5%
營業毛利(毛損)淨額26.6%33.8%38.9%39.0%31.9%37.6%41.3%40.0%42.3%41.5%
營業費用合計29.7%31.1%35.9%36.4%36.8%38.5%37.7%36.8%34.8%39.6%
營業利益(損失)-3.1%2.7%3.0%2.6%-4.9%-0.9%3.7%3.1%7.5%2.0%
稅前淨利(淨損)-2.2%3.1%4.7%4.9%-4.1%2.0%6.1%5.9%10.2%4.5%
所得稅費用(利益)合計0.1%0.4%0.3%0.6%-0.6%0.4%1.3%1.0%1.9%1.0%
繼續營業單位本期淨利(淨損)-2.4%2.7%4.4%4.3%-3.5%1.5%4.7%4.9%8.3%3.6%
本期淨利(淨損)-2.4%2.7%4.4%4.3%-3.5%1.5%4.7%4.9%8.3%3.6%
本期綜合損益總額-2.4%2.7%4.8%8.8%-3.6%1.3%6.5%15.7%19.2%16.2%
母公司業主(淨利∕損)-2.4%3.0%4.4%4.3%-3.5%1.5%4.7%4.8%8.3%3.5%
基本每股盈餘-0.1%0.1%0.2%0.2%-0.1%0.1%0.2%0.2%0.3%0.1%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。